An open-label pilot study of the efficacy and tolerability of once-daily didanosine versus twice-daily didanosine.
Keiser
P
P
University of Texas Southwestern Medical Center at Dallas, USA.
Turner
D
D
Ramilo
O
O
Kvanli
M B
MB
Smith
J W
JW
Nassar
N
N
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D016049:Didanosine / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010865:Pilot Projects; D019562:Viral Load
D019380:Anti-HIV Agents; D016049:Didanosine